It will be interesting to see what the FDA does with respect to the two doses for DME. Based on the data in #msg-64703260, the FDA can’t simply disregard the 0.3mg data as they did in the AMD label (#msg-11842516).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”